Tyler Booth, InterCommunity’s Chief Operating Officer, along with U.S. Sen. Richard Blumenthal, police, and paramedics spoke at a news conference on Tuesday, November 13, 2018, about the dangers of Dsuvia, a highly-potent synthetic opioid that has been approved by the FDA for use in health-care settings. The pill is scheduled to be released in January 2019. Read the full story from the Courant here.
The post News Conference Draws Attention to Potent New Opioid Pill appeared first on InterCommunity.
No one will be denied access to services due to inability to pay; and there is a discounted/sliding fee schedule available based on family size and income.
For all concerns of a compliance nature please send correspondence to compliance@intercommunityct.org
Or call our corporate compliance department at
860-569-5900
extension 364
For all concerns of a compliance nature please send correspondence to compliance@intercommunityct.org
Or call our corporate compliance department at:
860-569-5900
extension 364
© 2025 All Rights Reserved. InterCommunity inspires hope and promotes whole person health by providing high quality, affordable, compassionate healthcare for everyone. InterCommunity, Inc. is a 501(c)(3) organization. Your contribution is tax-deductible as allowed by law. Accessibility statement.